Active	Status	Sponsor type	Region	Phase	Filter
6 Active 3 Inactive 9 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « June » « 2025 » M T W T F S S 26 27 28 29 30 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4 5 6   - « June » « 2025 » M T W T F S S 26 27 28 29 30 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4 5 6   Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
RAMEL, Sophie
HomeCareSIMEOX, NCT04096664: Home Airway Clearance in CF Patients	Completed	N/A	143	Europe	SIMEOX	Physio-Assist, Icadom	Pulmonary Cystic Fibrosis	03/25	03/25
MuControl, NCT06147778: Performances and Safety of MuCopilot, a Digital Tool for the Unsupervised Objective Assessment of Cystic Fibrosis	Recruiting	N/A	70	Europe	MuCopilot mobile application	Ad scientiam, Vertex Pharmaceuticals Incorporated	Cystic Fibrosis	09/25	09/25

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
RAMEL, Sophie
HomeCareSIMEOX, NCT04096664: Home Airway Clearance in CF Patients	Completed	N/A	143	Europe	SIMEOX	Physio-Assist, Icadom	Pulmonary Cystic Fibrosis	03/25	03/25
MuControl, NCT06147778: Performances and Safety of MuCopilot, a Digital Tool for the Unsupervised Objective Assessment of Cystic Fibrosis	Recruiting	N/A	70	Europe	MuCopilot mobile application	Ad scientiam, Vertex Pharmaceuticals Incorporated	Cystic Fibrosis	09/25	09/25